A number of research analysts recently issued reports on FENC shares. Stephens upgraded Fennec Pharmaceuticals to a “strong-buy” rating in a research report on Monday, November 18th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback